0 CHECKOUT

PRODUCT FILTERS

REGION

18
11
7
6
6

COUNTRY

4
2
2
1
1

CATEGORIES

  • 15
  • 13
  • 7
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

13
14
20
64

PUBLISHED

0
8
20
64

PRODUCT TYPE

51
11
2

Search for: "Eisai: Pipeline, Products, Performance and Potential"

Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review

Eisai Co., Ltd. (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the...

Published:  March 2016
Price:  From

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions...

Published:  August 2012
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

Pharmaceutical Products of the Future: 50-Company Pipeline Analysis to 2015

What Will The Pharmaceutical Market Look Like in the Next Five Years? In this report, Kalorama has analyzed the late stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies...

Published:  July 2010
Price:  From

Venous (Vein) Thrombosis - Pipeline Review, H2 2015

Venous (Vein) Thrombosis - Pipeline Review, H2 2015 Summary The report ‘Venous (Vein) Thrombosis - Pipeline Review, H2 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline. This...

Published:  November 2015
Price:  From

Venous (Vein) Thrombosis - Pipeline Review, H1 2015

Venous (Vein) Thrombosis - Pipeline Review, H1 2015 Summary This, ‘Venous (Vein) Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline. This...

Published:  April 2015
Price:  From

RNAi Therapeutics Market, 2015 - 2030

Discovered less than two decades ago, RNAi has made its presence felt in all spheres of the pharmaceutical industry. RNAi is a natural post-transcriptional process of gene silencing involving short...

Published:  December 2015
Price:  From

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

The leading business intelligence provider, has released its latest research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance...

Published:  June 2014
Price:  From

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

This report provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides...

Published:  August 2014
Price:  From

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5 1 billion in 2013 to $7...

Published:  July 2014
Price:  From

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the Glioblastoma Multiforme (GBM) market. In newly diagnosed patients, the current...

Published:  June 2014
Price:  From

Antibody Drug Conjugates Market (3rd Edition)

The “Antibody Drug Conjugates Market (3rd edition), 2015-2025” report provides a comprehensive analysis of the current market landscape and future outlook of the growing pipeline of ADCs. The ADC market...

Published:  December 2015
Price:  From

Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022

Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022”....

Published:  February 2013
Price:  From

VX-765 (Epilepsy) - Forecast and Market Analysis to 2022

VX-765 (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “VX-765 (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy...

Published:  February 2013
Price:  From

Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022

Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Brivaracetam (Epilepsy) - Forecast and Market Analysis to...

Published:  February 2013
Price:  From

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

Biopharmaceuticals is currently one of the fastest growing segments in the pharmaceutical industry. They have a vital use in the treatment of chronic diseases and also result in high profit margins...

Published:  November 2015
Price:  From

Subcutaneous Biologics Market, 2015 - 2025

Amongst various efforts to ensure efficient drug delivery, subcutaneous administration has emerged as one of the most promising approaches to deliver viscous biologic drugs in a patient friendly format....

Published:  January 2015
Price:  From

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018 Summary Amyotrophic lateral sclerosis (ALS) is a rare, but fatal, motor neuron disease (MND) characterized...

Published:  June 2014
Price:  From

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

Published:  July 2015
Price:  From

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis By Product (Corticosteroids, Intravenous Immunoglobulin, Anti-D Immunoglobulin, TPO-RA) And Segment Forecasts To 2020

Global ITP therapeutics market is expected to reach USD 566.37 million by 2020. Introduction of new drugs especially pertaining to TPO-RA and IVIG classes is expected to serve this market as a high...

Published:  December 2014
Price:  From
Loading Indicator

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.